Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 1/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.38 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 5/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CETP | P11597 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29278844 | 0.80 | NOTUM (0.49) | SRD5A1NOTUMAADATRORCHTT | |
| SCHEMBL22298023 | 0.78 | SRD5A1 (0.42) | SRD5A1MTNR1APOLBTSHR | |
| SCHEMBL22298020 | 0.78 | MTNR1A (0.43) | SRD5A1MTNR1ADRD2LMNATSHR | |
| SCHEMBL2708840 | 0.77 | CETP (0.54) | NOTUMRORCCETP | |
| SCHEMBL30716840 | 0.77 | CETP (0.54) | NOTUMRORCCETP | |
| SCHEMBL431259 | 0.76 | SRD5A1 (0.41) | SRD5A1NOTUMRORCTRPV1 | |
| SCHEMBL20870358 | 0.74 | SRD5A1 (0.40) | SRD5A1MTNR1APOLB | |
| SCHEMBL6274932 | 0.74 | CETP (0.46) | NOTUMRORCCETP | |
| SCHEMBL6274933 | 0.74 | CETP (0.46) | NOTUMRORCCETP | |
| SCHEMBL22364516 | 0.73 | MTNR1A (0.61) | MTNR1APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020030814-A1 | METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2020-02-13 | — | — | WO | disclosed |